Chronic depolarization stimulates norepinephrine transporter expression via catecholamines

Journal of Neurochemistry

Volumn 97, Issue 4, 2006, Pages 1044-1051

  Habecker, Beth A ^a,c   Willison, Breanne D ^a   Shi, Xiao ^a   Woodward, William R ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

methyl p tyrosine; Depolarization; Norepinephrine uptake; Sepiapterin; Sympathetic neuron

Indexed keywords

CATECHOLAMINE; MESSENGER RNA; NORADRENALIN TRANSPORTER; TYROSINE 3 MONOOXYGENASE;

ARTICLE; CATECHOLAMINE SYNTHESIS; CELL STRAIN; CELL STRAIN SK N BE(2)M17; CHRONIC DEPOLARIZATION; CONTROLLED STUDY; DEPOLARIZATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; MODEL; NERVE CONDUCTION; NEUROBLASTOMA CELL; NORADRENALIN UPTAKE; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; SYMPATHETIC NERVE CELL;

ACTION POTENTIALS; CATECHOLAMINES; CELL LINE, TUMOR; CELLS, CULTURED; ENZYME INHIBITORS; GANGLIA, SYMPATHETIC; GENE EXPRESSION REGULATION; HUMANS; NEURONS; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; POTASSIUM CHLORIDE; RNA, MESSENGER; TYROSINE 3-MONOOXYGENASE; UP-REGULATION;

EID: 33646096446     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.03792.x     Document Type: Article

References (46)

1. Amara S. G. Kuhar M. J. 1993 Neurotransmitter transporters: recent progress. Annu. Rev. Neurosci. 16 73 93.
2. Apparsundaram S. Galli A. DeFelice L. J. Hartzell H. C. Blakely R. D. 1998a Acute regulation of norepinephrine transport: I. protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. J. Pharmacol. Exp. Ther. 287 733 743.
3. Apparsundaram S. Schroeter S. Giovanetti E. Blakely R. D. 1998b Acute regulation of norepinephrine transport. II. PKC-modulated surface expression of human norepinephrine transporter proteins. J. Pharmacol. Exp. Ther. 287 744 751.
4. Black I. B. Chikaraishi D. M. Lewis E. J. 1985 Trans-synaptic increase in RNA coding for tyrosine hydroxylase in a rat sympathetic ganglion. Brain Res. 339 151 153.
5. Blakely R. D. Bauman A. L. 2000 Biogenic amine transporters: regulation in flux. Curr. Opin. Neurobiol. 10 328 336.
6. Brosenitsch T. A. Katz D. M. 2001 Physiological patterns of electrical stimulation can induce neuronal gene expression by activating N-type calcium channels. J. Neurosci. 21 2571 2579.
7. Bunzow J. R. Sonders M. S. Arttamangkul S. et al. 2001 Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol. Pharmacol. 60 1181 1188.
8. Carboni E. Tanda G. L. Frau R. Di Chiara G. 1990 Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J. Neurochem. 55 1067 1070.
9. Eisenhofer G. Friberg P. Rundqvist B. Quyyumi A. A. Lambert G. Kaye D. M. Kopin I. J. Goldstein D. S. Esler M. D. 1996 Cardiac sympathetic nerve function in congestive heart failure. Circulation 93 1667 1676.
10. Esler M. Kaye D. Lambert G. Esler D. Jennings G. 1997 Adrenergic nervous system in heart failure. Am. J. Cardiol. 80 7L 14L.
11. Goldberg L. I. 1984 Dopamine receptors and hypertension. Physiologic and pharmacologic implications. Am. J. Med. 77 37 44.
12. Habecker B. A. Klein M. G. Cox B. C. Packard B. A. 2000 Norepinephrine transporter expression in cholinergic sympathetic neurons: differential regulation of membrane and vesicular transporters. Dev. Biol. 220 85 96.
13. Habecker B. A. Klein M. G. Sundgren N. C. Li W. Woodward W. R. 2002 Developmental regulation of neurotransmitter phenotype through tetrahydrobiopterin. J. Neurosci. 22 9445 9452.
14. Hawrot E. Patterson P. H. 1979 Long-term culture of dissociated sympathetic neurons. Meth. Enzymol. 58 574 584.
15. Hefti F. Gnahn H. Schwab M. E. Thoenen H. 1982 Induction of tyrosine hydroxylase by nerve growth factor and by elevated K+ concentrations in cultures of dissociated sympathetic neurons. J. Neurosci. 2 1554 1566.
16. Keller N. R. Diedrich A. Appalsamy M. Tuntrakool S. Lonce S. Finney C. Caron M. G. Robertson D. 2004 Norepinephrine transporter-deficient mice exhibit excessive tachycardia and elevated blood pressure with wakefulness and activity. Circulation 110 1191 1196.
17. Kumer S. C. Vrana K. E. 1996 Intricate regulation of tyrosine hydroxylase activity and gene expression. J. Neurochem. 67 443 462.
18. Lee C. M. Javitch J. A. Snyder S. H. 1983 Recognition sites for norepinephrine uptake: regulation by neurotransmitter. Science 220 626 629.
19. Li W. Knowlton D. Woodward W. R. Habecker B. A. 2003 Regulation of noradrenergic function by inflammatory cytokines and depolarization. J. Neurochem. 86 774 783.
20. Liang C. S. Yatani A. Himura Y. Kashiki M. Stevens S. Y. 2003 Desipramine attenuates loss of cardiac sympathetic neurotransmitters produced by congestive heart failure and NE infusion. Am. J. Physiol. Heart Circ. Physiol. 284 H1729 H1736.
21. Mao W. Qin F. Iwai C. Vulapalli R. Keng P. C. Liang C. S. 2004 Extracellular norepinephrine reduces neuronal uptake of norepinephrine by oxidative stress in PC12 cells. Am. J. Physiol. Heart Circ. Physiol. 287 H29 H39.
22. Melikian H. E. Ramamoorthy S. Tate C. G. Blakely R. D. 1996 Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition. Mol. Pharmacol. 50 266 276.
23. Moron J. A. Brockington A. Wise R. A. Rocha B. A. Hope B. T. 2002 Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J. Neurosci. 22 389 395.
24. Nguyen T. T. Amara S. G. 1996 N-linked oligosaccharides are required for cell surface expression of the norepinephrine transporter but do not influence substrate or inhibitor recognition. J. Neurochem. 67 645 655.
25. Pacholczyk T. Blakely R. D. Amara S. G. 1991 Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350 350 354.
26. Qin F. Vulapalli R. S. Stevens S. Y. Liang C. S. 2002 Loss of cardiac sympathetic neurotransmitters in heart failure and NE infusion is associated with reduced NGF. Am. J. Physiol. Heart Circ. Physiol. 282 H363 H371.
27. Raynaud B. Clarous D. Vidal S. Ferrand C. Weber M. J. 1987a Comparison of the effects of elevated K+ ions and muscle-conditioned medium on the neurotransmitter phenotype of cultured sympathetic neurons. Dev. Biol. 121 548 558.
28. Raynaud B. Faucon-Biguet N. Vidal S. Mallet J. Weber M. J. 1987b The use of a tyrosine-hydroxylase cDNA probe to study the neurotransmitter plasticity of rat sympathetic neurons in culture. Dev. Biol. 119 305 312.
29. Rittenhouse A. R. Zigmond R. E. 1991 Omega-conotoxin inhibits the acute activation of tyrosine hydroxylase and the stimulation of norepinephrine release by potassium depolarization of sympathetic nerve endings. J. Neurochem. 56 615 622.
30. Rittenhouse A. R. Zigmond R. E. 1999 Role of N- and l -type calcium channels in depolarization-induced activation of tyrosine hydroxylase and release of norepinephrine by sympathetic cell bodies and nerve terminals. J. Neurobiol. 40 137 148.
31. Savchenko V. Sung U. Blakely R. D. 2003 Cell surface trafficking of the antidepressant-sensitive norepinephrine transporter revealed with an ectodomain antibody. Mol. Cell Neurosci. 24 1131 1150.
32. Shannon J. R. Flattem N. L. Jordan J. Jacob G. Black B. K. Biaggioni I. Blakely R. D. Robertson D. 2000 Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N. Engl. J. Med. 342 541 549.
33. Singh K. K. Miller F. D. 2005 Activity regulates positive and negative neurotrophin-derived signals to determine axon competition. Neuron 45 837 845.
34. Sung U. Apparsundaram S. Galli A. Kahlig K. M. Savchenko V. Schroeter S. Quick M. W. Blakely R. D. 2003 A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity. J. Neurosci. 23 1697 1709.
35. Swann A. C. Duman R. Hewitt L. 1985 Desipramine binding: relationship to central and sympathetic noradrenergic activity. J. Neurochem. 44 611 615.
36. 2+ channels of the l -type in neurotransmitter plasticity of cultured sympathetic neurons. Brain Res. Mol. Brain Res. 6 187 196.
37. 2+ in the transmitter choice made by cultured sympathetic neurons. J. Neurosci. 1 343 350.
38. Walicke P. A. Campenot R. B. Patterson P. H. 1977 Determination of transmitter function by neuronal activity. Proc. Natl Acad. Sci. USA 74 5767 5771.
39. Weinshenker D. White S. S. Javors M. A. Palmiter R. D. Szot P. 2002 Regulation of norepinephrine transporter abundance by catecholamines and desipramine in vivo. Brain Res. 946 239 246.
40. Woodward W. R. Seil F. J. Hammerstad J. P. 1987 Cerebellum plus locus coeruleus in tissue culture. II. Development and metabolism of catecholamines. J. Neurosci. Res. 17 184 188.
41. Yamamoto B. K. Novotney S. 1998 Regulation of extracellular dopamine by the norepinephrine transporter. J. Neurochem. 71 274 280.
42. --dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol. Ther. 92 21 55.
43. Zhu M. Y. Ordway G. A. 1997 Down-regulation of norepinephrine transporters on PC12 cells by transporter inhibitors. J. Neurochem. 68 134 141.
44. Zhu M. Y. Kim C. H. Hwang D. Y. Baldessarini R. J. Kim K. S. 2002 Effects of desipramine treatment on norepinephrine transporter gene expression in the cultured SK-N-BE 2, M17 cells and rat brain tissue. J. Neurochem. 82 146 153.
45. Zigmond R. E. 1980 The long-term regulation of ganglionic tyrosine hydroxylase by preganglionic nerve activity. Fed. Proc. 39 3003 3008.
46. Zigmond R. E. Schwarzschild M. A. Rittenhouse A. R. 1989 Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation. Annu. Rev. Neurosci. 12 415 461.